Back to all bills
HR 3010119th CongressIntroduced
No Handouts for Drug Advertisements Act
Introduced: Oct 29, 2025
Economy & TaxesHealthcare
Standard Summary
Comprehensive overview in 1-2 paragraphs
The bill amends the Internal Revenue Code to prohibit tax deductions for direct-to-consumer advertising expenses of certain prescription drugs and compounded drugs, aiming to curb pharmaceutical industry incentives for consumer-targeted marketing.
Key Points
- 1Denies tax deductions for DTC advertising of covered drugs via media like TV, social media, and digital platforms
- 2Excludes advertisements in journals and periodicals from the DTC definition
- 3Defines covered entities as prescription drug sponsors and outsourcing facilities under FDCA regulations
Impact Areas
Pharmaceutical companiesHealthcare consumersHealthcare cost containment effortsIRS tax deduction enforcement
Generated by gpt-4o on Nov 6, 2025